Tumor- and Immune Cell-Derived Exosomes
-
- Seo Naohiro
- Department of Cancer Vaccine,Mie University Graduate School of Medicine
-
- Shiku Hiroshi
- Department of Cancer Vaccine,Mie University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 癌と免疫とエクソソーム
- ガン ト メンエキ ト エクソソーム
Search this article
Description
There are a few reports about the role of exosomes released from anti-tumor immune cells including T cells, NK cells, DCs or macrophages. On the other hand, it has been clarified that tumor cell-derived exosomes play a crucial role in the formation of tumor microenvironment and epithelial-mesenchymal transition (EMT) of tumors by cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) under the effect of exosomal microRNAs (miRs) and proteins. In addition, tumor-derived exosomes have been reported to attenuate tumoricidal immune responses. In this review, we describe the possibility of exosome-based tumor immunotherapy followed by understanding biological significances of immune cell- and tumor cell-derived exosomes.
Journal
-
- Drug Delivery System
-
Drug Delivery System 29 (2), 152-159, 2014
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679619494272
-
- NII Article ID
- 130004495152
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 025370590
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed